GlassScriptPhysician profile
Philip P Garrett
NPI 1578572012
$8,648.61
in general payments reported to CMS, 2019-2025
30 companies · $4,575 in 2025
The $4,575 reported for 2025 was more than what 93% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,469 · 2020: $184 · 2021: $748 · 2022: $352 · 2023: $436 · 2024: $884 · 2025: $4,575.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,875 · Food and Beverage: $1,970 · Travel and Lodging: $50.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,875.00 |
| Food and Beverage | $1,970.18 |
| Travel and Lodging | $50.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $4,410.61 | 2025 | |
| Osteomed LLC | $1,851.24 | 2019-2021 | |
| Smith+Nephew, INC. | $376.49 | 2019-2024 | Grafix Pl, Renasys Touch, Pico |
| Organogenesis INC. | $313.92 | 2022-2023 | Puraply |
| Progenacare Global, LLC | $277.98 | 2023-2024 | |
| Zimmer Biomet Holdings, INC. | $214.24 | 2019 | |
| Nevro Corp. | $176.38 | 2024 | Senza |
| Nextremity Solutions INC. | $158.27 | 2019-2021 | |
| Medtronic, INC. | $125.34 | 2022-2024 | |
| Melinta Therapeutics, LLC | $109.94 | 2024 | Kimyrsa |
| Vaporox, INC. | $91.72 | 2024 | Vht-200 Wound Treatment System |
| Novastep INC. | $65.09 | 2022-2025 | Nexis |
| Globus Medical, INC. | $54.21 | 2025 | Senza |
| Pacira Pharmaceuticals Incorporated | $44.11 | 2025 | Exparel |
| Depuy Synthes Sales INC. | $41.35 | 2023 | Va-Lcp |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Misonix INC | $40.10 | 2021 | |
| Heron Therapeutics, INC. | $35.64 | 2021-2022 | |
| Sebela Pharmaceuticals INC. | $29.43 | 2022-2023 | Naftin, Pramosone |
| Tactile Systems Technology INC | $29.06 | 2023 | Flexitouch Plus, Entre Plus |
| Ets Wound Care LLC | $27.36 | 2024 | Mirragen Advanced Wound Matrix |
| Supreme Orthopedic Systems, LLC | $25.15 | 2024 | |
| Acumed LLC | $22.66 | 2025 | Acumed, Osteomed |
| Orthofix Medical, INC. | $22.20 | 2021-2024 | Physio-Stim |
| Nabriva Therapeutics, Plc | $21.08 | 2021 | |
| Mimedx Group, INC. | $17.61 | 2024 | |
| Amgen INC. | $16.62 | 2024 | Krystexxa |
| Integra Lifesciences Corporation | $15.29 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Grt US Holding, INC. | $12.11 | 2022 | |
| Bioventus LLC | $12.07 | 2019 | |
| Horizon Therapeutics Plc | $11.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Garrett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.